Clinical Trial: ECOG-ACRIN EA8153

ECOG-ACRIN EA8153

Status: Closed

Cabazitaxel with Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial

EA8153 closed to accrual effective April 2, 2021.